Citation 122736

DOMINIC,YA: SUBBAIYAN,M:. (1993). STUDIES ON MACROMOLECULAR ALTERATIONS IN TUMOUR-BEARING RATS TREATED WITH OLEANOLIC ACID AND OLEANOLIC ACETATE.. 21(8)

Citation Details

Title	STUDIES ON MACROMOLECULAR ALTERATIONS IN TUMOUR-BEARING RATS TREATED WITH OLEANOLIC ACID AND OLEANOLIC ACETATE.
Authors	DOMINIC,YA: SUBBAIYAN,M:
Year	1993
Volume	21
Issue	8

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
2	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
3	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
4	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
5	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
6	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
7	MONOAMINE OXIDASE ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
8	GLYCOGEN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
9	GLYCOGEN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
10	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
11	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
12	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
13	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
14	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
15	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
16	GLYCOGEN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
17	GLYCOGEN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
18	GLYCOGEN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
19	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
20	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
21	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
22	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
23	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
24	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
25	HEXOSE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
26	HEXOSE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
27	HEXOSE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
28	HEXOSE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
29	HEXOSAMINE SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
30	HEXOSAMINE SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
31	HEXOSAMINE SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
32	HEXOSAMINE SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
33	SIALIC ACID SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
34	SIALIC ACID SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	WEAK ACTIVITY
35	SIALIC ACID SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
36	SIALIC ACID SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
2	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
3	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
4	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
5	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
6	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
7	GLYCOGEN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
8	GLYCOGEN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
9	GLYCOGEN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
10	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
11	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
12	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
13	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
14	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
15	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
16	GLYCOGEN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
17	GLYCOGEN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
18	GLYCOGEN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
19	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
20	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
21	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
22	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
23	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
24	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
25	HEXOSE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
26	HEXOSE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
27	HEXOSE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
28	HEXOSE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
29	HEXOSAMINE SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
30	HEXOSAMINE SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
31	HEXOSAMINE SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
32	HEXOSAMINE SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
33	SIALIC ACID SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
34	SIALIC ACID SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	WEAK ACTIVITY
35	SIALIC ACID SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE
36	SIALIC ACID SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID ACETATE	ACTIVE

Citation 122736

Citation Details

Summary

Organisms and Their Experiments (2)

Unknown organism

Unknown organism

Show SPARQL Queries (1)

Query 1